New Products: Cancer Genetics' MatBA-CLL/SLL Test | GenomeWeb

Cancer Genetics this week launched an updated version of its MatBA-CLL/SLL test for mature B-cell neoplasms, which provides greater clarity of risk and outcomes for patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.

According to the Rutherford, NJ-based company, its microarray-based test now reports information on twenty genomic sites, enabling the stratification of CLL and SLL patients into three distinct risk categories: favorable, intermediate, and unfavorable.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.